IMCR stock

Immunocore Holdings Ltd (IMCR) financials · rev $400.0M

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Immunocore Holdings Ltd (IMCR) rev $400.0M.

Cached annual income statement
LineFY2025FY2024
Revenue$400.0M$310.2M
Cost of Revenue$5.09M$2.73M
Gross Profit$394.9M$307.5M
Operating Income-$45.4M-$70.5M
Net Income-$35.5M-$51.1M
EPS (Diluted)-$0.71-$1.02
Cached annual balance sheet
LineFY2025FY2024
Total Assets$1.07B$1.01B
Current Assets$996.7M$929.9M
Cash & Equivalents$467.7M$455.7M
Inventory$6.74M$5.45M
PP&E$11.5M$10.1M
Total Liabilities$686.2M$648.8M
Current Liabilities$246.7M$212.2M
Shareholders' Equity$381.0M$360.7M
Retained Earnings-$831.3M-$795.8M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$10.7M$26.1M
CapEx$4.34M$5.17M
Investing Cash Flow-$16.3M-$355.1M
Financing Cash Flow$12.4M$343.9M
Free Cash Flow-$15.1M$20.9M
These statements as JSON? API free 100/day

FAQ

What is IMCR P/E and revenue?

Immunocore Holdings Ltd (IMCR) rev $400.0M.

What is IMCR revenue?

Immunocore Holdings Ltd last cached revenue is $400.0M (FY2025).

Is IMCR profitable?

Immunocore Holdings Ltd last cached net income is -$35.5M (FY2025).

What are IMCR total assets?

Immunocore Holdings Ltd last cached total assets are $1.07B (FY2025).

What is IMCR free cash flow?

Immunocore Holdings Ltd last cached free cash flow is -$15.1M (FY2025).

Not investment advice. Cached statements, not a live tape.